The mechanisms underlying the efficacy of the ketogenic diet (KD) remain unknown. Recently, we showed that the KD increased glutathione (GSH) biosynthesis. Since the NF E2-related factor 2 (Nrf2) transcription factor is a primary responder to cellular stress and can upregulate GSH biosynthesis, we asked whether the KD activates the Nrf2 pathway. Here we report that rats consuming a KD show acute production of H 2 O 2 from hippocampal mitochondria, which decreases below control levels by 3 weeks, suggestive of an adaptive response. 4-Hydroxy-2-nonenal (4-HNE), an electrophilic lipid peroxidation end product known to activate the Nrf2 detoxification pathway, was also acutely increased by the KD. Nrf2 nuclear accumulation was evident in both the hippocampus and liver, and the Nrf2 target, NAD(P)H:quinone oxidoreductase (NQO1), exhibited increased activity in both the hippocampus and liver after 3 weeks. We also found chronic depletion of liver tissue GSH, while liver mitochondrial antioxidant capacity was preserved. These data suggest that the KD initially produces mild oxidative and electrophilic stress, which may systemically activate the Nrf2 pathway via redox signaling, leading to chronic cellular adaptation, induction of protective proteins, and improvement of the mitochondrial redox state.
Introduction
The ketogenic diet (KD) has been successfully utilized since the 1920s as a treatment for intractable seizures in children. The diet consists of a regimen of high-fat and low-carbohydrate, most often in a 4:1 ratio, fat to nonfat. Despite its lengthy history, the mechanisms by which it confers an anticonvulsant effect remain unknown. It has been noted in the clinic, as well as in animal studies, that there is a lag between initiation of the diet and decrease in seizure frequency (Uhlemann and Neims, 1972; Appleton and DeVivo, 1974; Rho et al., 1999; Kossoff et al., 2008) . To date, the mechanisms underlying this phenomenon are poorly understood. Recent evidence suggests that chronic consumption of a KD may alter mitochondrial function by chronically decreasing production of reactive oxygen species (ROS), increasing the expression of uncoupling proteins, promoting mitochondrial biogenesis, and stimulating glutathione (GSH) biosynthesis (Sullivan et al., 2004; Bough et al., 2006; Jarrett et al., 2008) , all of which can be components of a cellular stress response (Shi et al., 1994; Tian et al., 1997; Sagara et al., 1998; Woods et al., 1999) .
The primary transcription factor responsible for initiating the response to oxidative stress is NF E2-related factor 2 (Nrf2). Nrf2 is a member of the cap 'n' collar family of basic leucine zipper proteins. Under normal conditions, Nrf2 is sequestered in the cytosol through its interaction with an inhibitory binding partner, Keap1. At steady state, Keap1 acts as an adaptor for an E3 ubiquitin ligase, thereby targeting Nrf2 to the proteasome for degradation (Kobayashi et al., 2004) . Oxidants and electrophiles can alter the binding interaction between Keap1 and Nrf2, allowing Nrf2 to dissociate and translocate into the nucleus where it binds DNA at a consensus sequence known as the antioxidant or electrophilic response element (ARE/EpRE) (Rushmore et al., 1991; Venugopal and Jaiswal, 1996) . In this way, Nrf2 regulates transcription of a large group of detoxification genes, among which are the subunits of glutamate cysteine ligase (GCL), the rate-limiting enzyme in GSH biosynthesis, which we previously found to be upregulated in the hippocampus of rats fed a KD for 3 weeks (Jarrett et al., 2008) . The goal of this study was to determine whether this cellular detoxification pathway was activated by the KD, as the Nrf2 pathway is a primary mechanism by which to induce GSH biosynthesis. Here we report that the KD produced a time-dependent change in hippocampal mitochondrial H 2 O 2 production, increases in 4-hydroxy-2-nonenal (4-HNE) levels, and Nrf2 activation, which may play a role in the protection afforded by the KD. Furthermore, in addition to the brain, we examined the possibility that the same pathways may be activated in the liver, due to the systemic effects of a dietary treatment. We found increased nuclear Nrf2 protein in the liver, as well as increased Nrf2 targets NAD(P)H:quinone oxidoreductase (NQO1) and heme oxygenase-1 (HO-1). Since the liver is known to supply extrahepatic tissues with GSH, we examined the 
